{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:42:00Z","timestamp":1760298120569},"reference-count":31,"publisher":"Wiley","issue":"S6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5417,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1002\/clc.4960231104","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T02:55:20Z","timestamp":1247712920000},"page":"8-13","source":"Crossref","is-referenced-by-count":6,"special_numbering":"supplement S6","title":["Optimizing Antiplatelet Therapy in Coronary Interventions"],"prefix":"10.1002","volume":"23","author":[{"given":"S. B.","family":"King III","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1002\/clc.4960231104-BIB1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.CIR.82.3.739","article-title":"Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry","volume":"82","author":"Detre","year":"1990","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0735-1097(92)90272-O","article-title":"Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile","volume":"19","author":"Lincoff","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960231104-BIB3","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/0002-9149(87)90479-6","article-title":"Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty","volume":"60","author":"Harker","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960231104-BIB4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.57.1.105","article-title":"Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model","volume":"57","author":"Steele","year":"1985","journal-title":"Circ Res"},{"key":"10.1002\/clc.4960231104-BIB5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"Br Med J"},{"key":"10.1002\/clc.4960231104-BIB6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.69.4.721","article-title":"Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study","volume":"69","author":"Thornton","year":"1984","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GPIIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"EPIC Investigators","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","author":"EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study","volume":"349","author":"The CAPTURE Investigators","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","author":"EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB12","doi-asserted-by":"crossref","first-page":"63P","DOI":"10.1016\/S0002-9149(98)00664-X","article-title":"Evolution of improved antithrombotic and antiplatelet agents: Genesis of the Comparison of Abciximab Complications with Hirulog [and Back-Up Abciximab] Events Trial (CACHET)","volume":"82","author":"Topol","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960231104-BIB13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","article-title":"Complementary clinical benefits of coronaryartery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors","volume":"341","author":"Lincoff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.98.11.1085","article-title":"Abciximab (Reo-Pro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb\/IIIa and \u03b1vb\u03033 integrins","volume":"98","author":"Tam","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB15","first-page":"I","article-title":"Improved cardiac outcomes in diabetic unstable angina\/non-Q-wave myocardial infarction patients treated with tirofiban and heparin (abstr 1889)","volume":"98","author":"Th\u00e9roux","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","article-title":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II","volume":"349","author":"The IMPACT-II Investigators","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty","volume":"96","author":"The RESTORE Investigators","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.CIR.98.13.1268","article-title":"Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb\/IIIa receptor blockade with oral xemilofiban. Results of a multicenter, placebo-controlled, randomized trial","volume":"98","author":"Kereiakes","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM200005043421803","volume":"342","author":"O'Neill","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB20","first-page":"I","article-title":"Pretreatment with ticlopidine prior to stenting is associated with a substantial decrease in complications: Data from the EPISTENT trial (abstr 3016)","volume":"98","author":"Steinhubl","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) Study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB23","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231104-BIB24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB25","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation","volume":"99","author":"Moussa","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/clc.4960231104-BIB27","first-page":"I","article-title":"Benefit of clopidogrel in patients with coronary disease (abstr 2608)","volume":"96","author":"Gent","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB28","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.98.22.2461","article-title":"Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates","volume":"98","author":"Harker","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231104-BIB29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0735-1097(99)00442-8","article-title":"Clopidogrel versus ticlopidine after intracoronary stent placement","volume":"34","author":"Berger","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960231104-BIB30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1008981408216","article-title":"Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting","volume":"7","author":"Steinhubl","year":"1999","journal-title":"J Thrombosis Thrombolysis"},{"key":"10.1002\/clc.4960231104-BIB31","first-page":"15","article-title":"Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects","volume":"25","author":"Savcic","year":"1999","journal-title":"Semin Thromb Hemost"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960231104","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/clc.4960231104\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:54:47Z","timestamp":1625169287000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960231104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":31,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2000,11]]}},"URL":"https:\/\/doi.org\/10.1002\/clc.4960231104","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}